Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mariano Esteban

Showing results (51-60 of 256) with videos related to

Pageof 26
Sort By:
Vaccine|December 25, 2010
Immunization with recombinant DNA and modified vaccinia virus Ankara (MVA) vectors delivering PSCA and STEAP1 antigens inhibits prostate cancer progressionMagdalena Krupa, Marta Canamero, Carmen E Gomez, et al.
Virology Journal|September 15, 2005
Involvement of PKR and RNase L in translational control and induction of apoptosis after Hepatitis C polyprotein expression from a vaccinia virus recombinantCarmen E Gómez, Andrée Marie Vandermeeren, María Angel García, et al.
Journal of Virology|May 30, 2006
Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L geneJosé Luis Nájera, Carmen Elena Gómez, Elena Domingo-Gil, et al.
The Archives of Bone and Joint Surgery|February 20, 2016
Sleep Disturbance and Upper-Extremity DisabilityRinne Marijn Peters, Mariano Esteban Menendez, Jos Jasper Mellema, et al.
Plos One|July 5, 2013
Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling PathwaysJuan García-Arriaza, Pilar Arnáez, Carmen E Gómez, et al.
Plos Neglected Tropical Diseases|October 31, 2017
Complex antigen presentation pathway for an HLA-A*0201-restricted epitope from Chikungunya 6K proteinElena Lorente, Alejandro Barriga, Juan García-Arriaza, et al.
The World Journal of Men'S Health|March 11, 2022
Testosterone Recovery after Androgen Deprivation Therapy in Prostate Cancer: Building a Predictive ModelÁngel Borque-Fernando, Fernando Estrada-Domínguez, Luis Mariano Esteban, et al.
Microbes and Infection|March 26, 2003
The combination of DNA vectors expressing IL-12 + IL-18 elicits high protective immune response against cutaneous leishmaniasis after priming with DNA-p36/LACK and the cytokines, followed by a booster with a vaccinia virus recombinant expressing p36/LACKEsther Tapia, Eva Pérez-Jiménez, Laura López-Fuertes, et al.
Plos One|June 21, 2012
High quality long-term CD4+ and CD8+ effector memory populations stimulated by DNA-LACK/MVA-LACK regimen in Leishmania major BALB/c model of infectionLucas Sánchez-Sampedro, Carmen Elena Gómez, Ernesto Mejías-Pérez, et al.
Plos One|September 3, 2010
Immunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletionsJuan García-Arriaza, José Luis Nájera, Carmen E Gómez, et al.
Pageof 26

Showing results (51-60 of 256) with videos related to

Sort By:
Pageof 26
Vaccine|December 25, 2010
Immunization with recombinant DNA and modified vaccinia virus Ankara (MVA) vectors delivering PSCA and STEAP1 antigens inhibits prostate cancer progressionMagdalena Krupa, Marta Canamero, Carmen E Gomez, et al.
Virology Journal|September 15, 2005
Involvement of PKR and RNase L in translational control and induction of apoptosis after Hepatitis C polyprotein expression from a vaccinia virus recombinantCarmen E Gómez, Andrée Marie Vandermeeren, María Angel García, et al.
Journal of Virology|May 30, 2006
Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L geneJosé Luis Nájera, Carmen Elena Gómez, Elena Domingo-Gil, et al.
The Archives of Bone and Joint Surgery|February 20, 2016
Sleep Disturbance and Upper-Extremity DisabilityRinne Marijn Peters, Mariano Esteban Menendez, Jos Jasper Mellema, et al.
Plos One|July 5, 2013
Improving Adaptive and Memory Immune Responses of an HIV/AIDS Vaccine Candidate MVA-B by Deletion of Vaccinia Virus Genes (C6L and K7R) Blocking Interferon Signaling PathwaysJuan García-Arriaza, Pilar Arnáez, Carmen E Gómez, et al.
Plos Neglected Tropical Diseases|October 31, 2017
Complex antigen presentation pathway for an HLA-A*0201-restricted epitope from Chikungunya 6K proteinElena Lorente, Alejandro Barriga, Juan García-Arriaza, et al.
The World Journal of Men'S Health|March 11, 2022
Testosterone Recovery after Androgen Deprivation Therapy in Prostate Cancer: Building a Predictive ModelÁngel Borque-Fernando, Fernando Estrada-Domínguez, Luis Mariano Esteban, et al.
Microbes and Infection|March 26, 2003
The combination of DNA vectors expressing IL-12 + IL-18 elicits high protective immune response against cutaneous leishmaniasis after priming with DNA-p36/LACK and the cytokines, followed by a booster with a vaccinia virus recombinant expressing p36/LACKEsther Tapia, Eva Pérez-Jiménez, Laura López-Fuertes, et al.
Plos One|June 21, 2012
High quality long-term CD4+ and CD8+ effector memory populations stimulated by DNA-LACK/MVA-LACK regimen in Leishmania major BALB/c model of infectionLucas Sánchez-Sampedro, Carmen Elena Gómez, Ernesto Mejías-Pérez, et al.
Plos One|September 3, 2010
Immunogenic profiling in mice of a HIV/AIDS vaccine candidate (MVA-B) expressing four HIV-1 antigens and potentiation by specific gene deletionsJuan García-Arriaza, José Luis Nájera, Carmen E Gómez, et al.
Pageof 26